mRNA-1273.222
- Generic Name
- mRNA-1273.222
A Study of mRNA-1283 Injection Compared With mRNA-1273 Injection in Participants ≥12 Years of Age to Prevent COVID-19
- Conditions
- COVID-19
- Interventions
- First Posted Date
- 2023-04-18
- Last Posted Date
- 2025-05-07
- Lead Sponsor
- ModernaTX, Inc.
- Target Recruit Count
- 14246
- Registration Number
- NCT05815498
- Locations
- 🇺🇸
Mountain View Ogden Clinic/CCT Research, Pleasant View, Utah, United States
🇺🇸JBR Clinical Research, Salt Lake City, Utah, United States
🇺🇸J. Lewis Research, Inc. / Foothill Family Clinic South, Salt Lake City, Utah, United States
A Study to Evaluate the Immunogenicity and Safety of mRNA Vaccine Boosters for SARS-CoV-2 (COVID-19) Variants
- Conditions
- SARS-CoV-2
- Interventions
- First Posted Date
- 2021-06-15
- Last Posted Date
- 2025-02-28
- Lead Sponsor
- ModernaTX, Inc.
- Target Recruit Count
- 5161
- Registration Number
- NCT04927065
- Locations
- 🇺🇸
Research Centers of America, Hollywood, Florida, United States
🇺🇸Jacksonville Center For Clinical Research, Jacksonville, Florida, United States
🇺🇸Meridian Clinical Research (Iowa), Sioux City, Iowa, United States
Delayed Heterologous SARS-CoV-2 Vaccine Dosing (Boost) After Receipt of EUA Vaccines
- Conditions
- COVID-19
- Interventions
- First Posted Date
- 2021-05-17
- Last Posted Date
- 2025-04-20
- Target Recruit Count
- 867
- Registration Number
- NCT04889209
- Locations
- 🇺🇸
University of Rochester Medical Center - Vaccine Research Unit, Rochester, New York, United States
🇺🇸Cincinnati Children's Hospital Medical Center Vaccine Research Center, Cincinnati, Ohio, United States
🇺🇸University of Pittsburgh - Medicine - Infectious Diseases, Pittsburgh, Pennsylvania, United States
A Study to Evaluate the Safety, Reactogenicity, and Effectiveness of mRNA-1273 Vaccine in Adolescents 12 to <18 Years Old to Prevent COVID-19
- Conditions
- SARS-CoV-2
- Interventions
- First Posted Date
- 2020-12-02
- Last Posted Date
- 2024-10-22
- Lead Sponsor
- ModernaTX, Inc.
- Target Recruit Count
- 4331
- Registration Number
- NCT04649151
- Locations
- 🇺🇸
Velocity Clinical Research - Banning, Banning, California, United States
🇺🇸Paradigm Clinical Research, La Mesa, California, United States
🇺🇸Altus Research - Hunt - PPDS, Lake Worth, Florida, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.